A Study of Clinical Profile of Hyperglycemic Seizures by Balamurugan, P
 1
THE TAMILNADU Dr. M.G.R. MEDICAL UNIVERSITY 
CHENNAI – TAMILNADU. 
 
 
 
 
 
 
 
 
DISSERTATION  
ON  
 
A STUDY OF CLINICAL PROFILE OF 
HYPERGLYCEMIC SEIZURES 
 
 
 
 
 
SUBMITTED FOR M.D. DEGREE EXAMINATION 
BRANCH I 
(GENERAL MEDICINE) 
 
EXAMINATION  
IN 
MARCH – 2007 
 
 
 
 
 
THANJAVUR MEDICAL COLLEGE 
THANJAVUR 
 
 
 2
CERTIFICATE 
 
This is to certify that this dissertation entitled “A STUDY OF 
CLINICAL PROFILE OF HYPERGLYCEMIC SEIZURES” is the 
bonafide record work done by Dr. P. BALAMURUGAN, submitted as 
partial fulfillment for the requirements of M.D. Degree Examinations, 
General Medicine (Branch I) to be held in March 2007. 
 
 
 
 
 
 
 
Prof. Dr. K. GANDHI, M.D.,            Prof. Dr. A. SUKUMARAN, M.D.,                   
Professor and H.O.D,     Additional Professor of Medicine,                       
Department of Medicine,    Unit Chief M VI, 
Thanjavur Medical College Hospital,  Department of Medicine,                   
Thanjavur.            Thanjavur Medical College Hospital, 
          Thanjavur. 
 
 
 
 
 
THE DEAN, 
Thanjavur Medical College, 
Thanjavur. 
 
 
 3
ACKNOWLEDGEMENT 
 
 
 
I am extremely grateful to Dr. S. BALAKRISHNAN, M.D.,  
THE DEAN, Thanjavur Medical College for granting me permission to 
do this dissertation work in Thanjavur Medical college Hospital, 
Thanjavur. 
 
I express my deep sense of gratitude to my beloved                 
Prof. Dr. A. SUKUMARAN, M.D., Additional Professor of Medicine, 
My Unit Chief, My teacher and My guide, who provided constant 
Guidance and advise throughout this study and without whose initiative 
and enthusiasm this study would not have been completed. 
 
I express my sincere gratitude to professor and Head of the 
Department of medicine Prof. Dr. K. GANDHI, M.D., for his valuable 
support and guidance in preparing this dissertation. 
 
I would like to gratefully acknowledge the help rendered by                             
Prof. Dr. P. S. GANESAN, M.D., D.M. (Neuro), Professor of 
Neurology, Asst. Prof. Dr. M. THANGARAJ, M.D., D.M., and                        
Asst. Prof. Dr. M. ANGURAJ, M.D., D.M., who was kind enough to 
guide me throughout this study. 
 4
 
I am thankful to my beloved Assistant Professors                       
Dr. C. PARANTHAKAN, M.D., Dr. S. PALANIYANDI, M.D.,     
Dr. P. KUMAR, M.D., of my unit for their guidance and help 
throughout this work. 
 
I thank the Radiology and Biochemistry Department for their help 
in investigation aspects. 
  
I express my gratitude to all the patients who participated in this 
study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 5
 
 
 
 
 
 
 
 
CONTENTS 
 
 
Page No. 
 
1. INTRODUCTION      1            
2. AIM OF THE STUDY      2 
3. REVIEW OF LITERATURE    3 
4. MATERIALS AND METHODS             38          
5. RESULTS AND OBSERVATION                   41 
6. DISCUSSION                 49 
7. CONCLUSION                56         
                  
BIBLIOGRAPHY 
PROFORMA                         
MASTER CHART 
 
 
 
 
 
 
 
 
 6
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 7
 
INTRODUCTION 
 
 
Seizures associated with Non Ketotic Hyperglycemia is now more 
commonly recognised new entity among adults in our area. 
 
HYPERGLYCEMIC SEIZURE – a special Neuroendocrine 
syndrome most commonly due to Non Ketotic Hyperglycemia has got 
its unique way of presentation, the clinical recognition of this entity was 
first made by MACCAIRO in 1965.39 
 
The seizures may be the initial manifestation of Diabetes 
Mellitus.  In the recent years clinical and experimental studies in 
animals, apart from routine investigations, CT Scan Brain, EEG and 
SPECT Scan were done to evaluate this entity.  The clinical presentation 
of hyperglycemic seizures associated with Non Ketotic Hyperglycemia 
is studied only by few authors. 
 
The real clinical picture needs further studies and evaluation and 
with this background, we evaluated clinical findings and investigations 
in all patients with hyperglycemic seizures. 
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AIM OF THE STUDY 
 
1. To study the clinical profile of Hyperglycemic Seizure (HGS). 
 
2. To map out the age and sex incidence of Hyperglycemic Seizure 
(HGS). 
 
3. To analyse the commonly occurring type of seizure in 
Hyperglycemic Seizure and to know the post seizure out come. 
 
4. To evaluate the blood sugar levels with which Hyperglycemic 
Seizure occurs. 
 
5. To decide the level of serum osmolalilty with which commonly 
Hyperglycemic Seizure occurs. 
 
6. To know the associated CNS / Systemic problems. 
 
7. To determine the best line and outcome of management. 
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REVIEW OF LITERATURE 
 
 The occurrence of seizures as a presenting feature of 
Hyperglycemia was first reported by Maccario et al in 1965.  But its 
clinical recognition at present is common among neurologists and 
uncommon among General Practitioners. 
 The metabolic causes of seizure in patients in particular diabetes 
mellitus with Non ketotic hyperglycemia (NKH) and its association with 
focal seizures were recognized only in the last decade both in India and 
around the world. 
 There is more than five papers in India including Paediatric 
population and greater than 30 papers have been published throughout 
the world including English and other languages (Data details collected 
through Internet). 
Definition of diabetes mellitus (Joslin)1  
 Diabetes mellitus is a syndrome, characterized by chronic 
hyperglycemia with disturbances of carbohydrate, fat and protein 
metabolism resulting from defects in insulin secretion, insulin action or 
both. 
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 When fully expressed, diabetes is characterized by fasting 
hyperglycemia, but the disease can also be recognized during less overt 
stages and before fasting hyperglycemia appears, most usually by the 
presence of glucose intolerance. 
 Diabetes Mellitus may be suspected or recognised clinically by 
the presence of characteristic symptoms such as excessive thirst, 
polyuria, polyphagia otherwise unexplained weight loss, and in its most 
severe forms, with ketoacidosis or non ketotic Hyperosmolality of 
which, in the absence of effective treatment, leads to stupor, coma and 
death. 
RISING GLOBAL BURDEN OF DIABETES1,6 
 Diabetes is one of the most common Non Communicable disease 
occurring globally. 
 In 1997 an estimated 123 million people have diabetes globally, 
or about 2.1% of world population. 
 By the year 2010, the total number of people with diabetes 
projected to reach 221 million world wide. 
 Globally, there are more women with Diabetes than men.  Recent 
studies put the numbers 62 million, at 73 million versus respectively. 
 Asia is likely to have 61% of the total globally projected number 
of people with Diabetes by 2010. 
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Newer Etiological classification of diabetes mellitus4,6 
(Adapted from American Diabetes Association, 2004) 
I. Type 1 diabetes (β-cell destruction, usually to absolute insulin 
deficiency) 
a. Immune-mediated. 
b. Idiopathic 
II. Type 2 diabetes (may range from predominantly insulin 
resistance with relative insulin deficiency to a predominantly 
insulin secretory defect with insulin resistance) 
III. Other specific types of diabetes 
a. Genetic defects of β-cell function characterized by 
mutations in: 
i. Hepatocyte nuclear transcription factor (HNF) 4α 
(MODY 1) 
ii. Glucokinase (MODY 2) 
iii. HNF-1 α (MODY 3)  
iv. Insulin promoter factor (IPF) 1 (MODY 4) 
v. HNF-1 β (MODY 5) 
vi. NeuruoD1 (MOD V 6) 
vii. Mitochondrial DNA 
viii. Proinsulin or insulin conversion. 
b. Genetic defects in insulin action 
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i. Type A insulin resistance 
ii. Leprechaunism 
iii. Rabson-Mendenhall syndrome 
iv. Lipodystrophy syndromes 
c. Diseases of the exocrine pancreas – pancreatitis, 
pancreatectomy, neoplasia, cystic fibrosis, 
hemochromatosis, fibrocalculous pancreatopathy. 
d. Endocrinopathies – acromegaly, Cushing’s syndrome, 
glucagonoma, pheochromocytoma, hyperthyroidism 
somatostatinoma, aldosteronoma. 
e. Drug – or chemical-induced – Vacor, pentamidine, 
nicotinic acid, glucocorticoids, thyroid hormone, diazoxide, 
β-adrenergic agonists, thiazides, phenytoin, α-interferon, 
protease inhibitors, clozapine, beta blockers. 
f. Infections – congenital rubella, cytomegalovirus, 
coxsackie. 
g. Uncommon forms of, immune-mediated diabetes – “stiff-
man” syndrome, anti-insulin, receptor antibodies. 
h. Other genetic syndromes sometimes associated with 
diabetes – Down’s syndrome, Klinefelter’s syndrome.  
Turner’s syndrome, Wolfram’s syndromes, /friedreich’s 
ataxia, Huntington’s chorea.  Laurence-Moon=biedl 
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syndrome, myotonic dystrophy, porphyia, Prader-Willi 
syndrome. 
IV. Gestational diabetes mellitus (GDM). 
 
New diagnostic criteria for diabetes mellitus1,4,6 
1. Symptoms of Diabetes plus casual Plasma glucose concentration 
> 200 mg / dl (11.1 mmol/L).  Casual Glucose is defined as 
plasma glucose levels at any time of day without regard to time 
since last meal. 
2. FPG > = 126 mg/dl (7.0 mmol/L).  Fasting is defined as no 
caloric intake for atleast 8 hours. 
3. 2 hour PG > = 200 mg/dl (11.1 mmol/L) during an OGTT.  The 
test should be performed as described by WHO, using a glucose 
load containing the equivalent of 75 gm anhydrous glucose 
dissolved in water.  The third measure [OGTT] is not 
recommended for routine clinical use. 
Criteria: 
 When any one of the above 3 criteria’s are positive it has to be 
confirmed on any subsequent day to any one of the above 3 tests. 
Epilepsy:3 
 Lord Russell Brain gave a more detailed definition.  According to 
him, an epileptic seizure is defined as an “intermittent stereotyped 
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disturbance of consciousness, behavior, emotion, motor function or 
sensation that on clinical grounds is believed to result from cortical 
neuronal discharge”. 
  
Nature of discharging lesion3,12,13 
 Seizure discharge can be initiated in an entirely normal cerebral 
cortex, as happens when the cortex is activated by administration of 
drugs; withdrawal of alcohol or other sedative or by repeated stimulation 
by sub-convulsive pulses (kindling phenomenon).  The electrical 
properties of a cortical epileptogenic focus suggest that its neurons have 
an increased ionic permeability that renders them suspeceptible to 
activation by hypothermia, hypoxia, hypoglycemia, hypocalcaemia and 
hyponatermia, repeated sensory stimulation and during some phases of 
sleep.  Epileptic foci are characterized by spontaneous inter-ictal 
discharges during which neurons of the discharging focus exhibit large 
calcium mediated PDS followed by prolonged, after Hyper Polarisation 
(AHP).  The AHP are due to Calcium dependent K+ currents, better 
explained by enhanced synaptic inhibition.  The PDS summate to 
produce surface recorded inter-ictal EEG spikes.  The AHP correspond 
to show wave of EEG spike and wave complex. 
 The neurons surrounding the epileptogenic focus are hyper 
polarized from the beginning and are GABA ergic inhibitory neurons 
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within the focus.  Seizure spread depends on any factor or agent that 
activates the neurons within the focus or inhibits the surroundings 
neurons. 
 
 The level of extra cellular Potassium is elevated in glial scars near 
epileptic foci and a defect in voltage sensitive Calcium channels has 
been postulated.  Deficiency of neuro-transmitter GABA, increased 
Glycine, decreased taurine, decreased and increased glutamic acid etc. 
have been reported in human epileptogenic tissue. 
 Firing of epileptogenic neurons in cortical focus is reflected in 
EEG as a series of spike wave discharges that increase progressively in 
amplitude and frequency.  Once the intensity of seizure discharge 
exceeds a certain limit it overcomes the inhibitory influences of the 
surrounding neurons and spreads to neighbouring cortical and 
subcortical synaptic connections. 
 If unchecked the cortical spreads to the adjacent cortex and the 
contra lateral cortex via the inter-hemisphere pathways.  The first 
clinical manifestations depend on the part of the brain from which the 
seizure originates.  There is propagation to sub-cortical nuclei and spinal 
neurons via the corticospinal and reticulospinal pathways.  The spread 
of excitation to the sub-cortical and brainstem centers corresponds to the 
tonic phase of the seizure, loss of consciousness and signs of autonomic 
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over activity.  Soon after the spread of inhibition a diencephalo-cortical 
inhibition beings and intermittently interrupts the seizure discharge, 
changing it from tonic to clonic phase.  
The intermittent clonic burst becomes less and less frequent and 
eventually ceases completely leaving in their awake exhausted neurons 
in the epileptogenic focus and increased permeability of the blood brain 
barrier.  These changes form the basis of Todd’s post-epileptic paralysis.  
There is 2 – 3 fold increase in the glucose utilization of neurons during 
seizure discharge and the paralysis could be due to neuronal depletion of 
glucose and accumulation of lactate. 
 The spike and wave complex which represents brief excitation 
followed by slow wave inhibition is the type of pattern that characterizes 
the clonic (inhibitory) phase of focal motor or Grandmal seizures.  
Temporal lobe seizures arise in the medial temporal lobe, amygdaloid 
nuclei and hippocampus.  They may also arise in the convexity of the 
temporal lobe.  Loss of memory for events of the episode is due to the 
paralytic effect of the neuronal discharge in the hippocampus.  The 
seizure focus may establish a persistent secondary focus in the 
corresponding control area of the opposite hemisphere via cortical 
connection called mirror focus.  The mirror form is the source of 
confusion in trying to identify the side of the primary lesion by EEG. 
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 Severe seizures may cause systemic lactic acidosis with fall in 
arterial pH, reduction in arterial O2 saturation and rise in PCO2 which 
are secondary to respiratory spasm and excessive muscular activity.  
Heart rate, blood pressure and CSF pressure rise during seizure.  
The rise in BP evoked by seizure causes significant increase in 
cerebral blood flow to meet the increased metabolic needs of the brain. 
In 1929, Dr. HarisBergers reported that interictal EEG changes 
were common in Epilepsy. 
Classification of seizure and Epilepsy syndrome7,9 
 An epilepsy syndrome is a composite of signs and symptoms 
associated with certain pathology or etiology (idiopathic) many of the 
idiopathic syndromes are inherited.  Syndromic classification is useful 
because some of the syndromes have well defined prognosis. 
 An International League Against Epilepsy [ILAE] to develop in 
1981 a classification of Epileptic seizure.  The classification makes use 
of both clinical and EEG information.  Classification of different 
epileptic syndromes based on seizure types occurring within the 
syndrome; age of onset and etiology will be of vital importance in the 
management of patients with epilepsy.  The classification of seizures is 
constantly being modified.  In the latest version (Epilepsia 30: 389, 
1989); an attempt has been made to incorporate all of the epilepsies, 
epileptic syndrome and related seizure disorders and to categories them 
not only as partial or generalized; but also according to the age of onset, 
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primary or secondary nature of the seizure and the many clinical settings 
in which they occur.  (Adapted from commission on the terminology 
and classification of International League Against Epilepsy.  Epilepsia: 
26, 268-275/1985). 
International classification of epileptic seizures 
Partial (Focal, Local) seizures 
Simple partial seizure (without impairment of consciousness)  
 With motor signs 
 With sensory symptoms 
 With autonomic symptoms or signs  
 With psychic symptoms 
Complex partial seizures (with impairment of consciousness) 
 Simple partial onset followed by impairment of consciousness  
With simple partial features followed by impaired consciousness 
 With automatisms 
 With impairment of consciousness at onset 
 With impairment of consciousness only 
 With automatisms 
Partial seizures evolving to secondary generalized seizures  
 Simple partial seizures evolving to generalized seizures 
 Complex partial seizures evolving to generalized seizures 
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Simple partial seizures evolving to complex partial seizures 
evolving to generalized seizures 
 
 
 
 
 
Generalized seizures 
Absence seizures 
Absences 
Atypical absences 
Myoclonic seizures 
Tonic seizures 
Atonic seizures 
Clonic seizures 
Tonic-clonic seizures 
 
International classification of epilepsies and epileptic syndromes 
Focal epilepsies / epileptic syndromes: 
Idiopathic: 
 Benign childhood epilepsy with centrotemporal spikes  
Childhood epilepsy with occipital paroxysms  
Primary reading epilepsy 
Symptomatic 
 Chronic progressive epilepsia partialis continua of childhood 
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Epilepsy characterized by seizures with specific modes of 
precipitation 
Cryptogenic 
The symptomatic and cryptogenic categories comprise syndrome 
of great individual variability that are based mainly on: 
Seizure types (according to International Classification of 
Epileptic Seizures) 
Anatomic localization: 
Temporal lobe epilepsies 
Frontal lobe epilepsies 
Parietal lobe epilepsies 
Occipital lobe epilepsies 
Bi-and multilobar epilepsies 
Etiology (for symptomatic epilepsies) 
Specific modes of precipitation 
Generalized Epilepsies / Epileptic syndromes  
Idiopathic: 
 Benign familial neonatal convulsions 
 Benign neonatal convulsions 
 Benign myoclonic epilepsies of infancy  
 Childhood absence epilepsy (pyknolepsy) 
 Juvenile absence epilepsy 
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 Juvenile myoclonic epilepsy 
 Epilepsy with grand mal (GTC) seizures on awaking  
 Other idiopathic generalized epilepsies not defined above  
Epilepsy with seizures precipitated by specific modes of 
activation 
Cryptogenic  
 West syndrome 
 Lennox-Gastaut syndrome 
 Epilepsy with myoclonic-astatic seizures 
 Epilepsy with myoclonic absences 
Symptomatic 
Non-specific etiology 
 Early myoclonic encephalopathy 
 Early infantile encephalopathy with suppression bursts  
 Others symptomatic generalized epilepsies not defined above  
Specific syndrome 
Neonate 
 Non-ketotic hyperglycemia 
 D-glyceridacidemia 
Seizure precipitants 9 
Seizure precipitants are those circumstances that precede the 
onset of on epileptic attack and are considered by both patient and 
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neurologist to be possible explanation for why the seizure happened 
when it did and not earlier (or) later. 
 Seizure precipitating (or) triggering factors involve chemical or 
physiologic stimulation capable of precipitating factors. 
 
Common seizures precipitants: 
1. Sleep deprivation 
2. Sudden awakening 
3. Fatigue and exercise 
4. Alcohol 
5. Missed antiepileptic medication 
6. Drugs lowering seizure threshold 
7. Hyperventilation 
8. Metabolic factors like Hypenatremia (or) hyponatermia, 
Hypocalcemia, Hypoglycemia. 
9. Fever. 
Triggered seizures 
Seizure may be triggered by specific stimuli. 
1. Visual stimuli 
2. Auditory stimuli 
3. Somatosensory stimuli 
4. Complex stimuli 
 25
5. Self induced seizure. 
Modulators of seizure occurrence  
1. Sleep 
2. Hormones of catamenial epilepsy 
3. Emotional situations. 
CLINICAL FEATURES 
The clinical symptoms and signs of partial seizures (simple and 
complex) are discussed here. 
Simple Partial Seizures: 9, 14 
Any part of the body may be involved in a focal seizure 
depending on the site of epileptic discharge in the motor cortex.  It may 
be in the form of jacksonian march, speech arrest or partial dysphasia or 
epileptic pallilalia.  Todd’s paralysis may follow a focal seizure and lasts 
for minutes to hours. 
Partial seizures with autonomic symptoms: 
 Rarely partial seizures may manifest by autonomic disturbance 
such as vomiting, pallor, flushing, sweating and pupillary dilatation. 
Partial seizures with somatosensory or special sensory 
symptoms:14,12 
 These arise from the sensory cortex and may march in a manner 
akin to motor seizures.  Special sensory seizures consist of auditory, 
gustatory, olfactory (uncinate seizures) and visual phenomena.  
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Vertiginous hallucinations like intense feeling of dizziness can 
sometimes occur. 
 
 
 
Complex partial seizures: 15, 17, 18 
 The most common type of complex partial seizures, occurring in 
over 90% of patients, is that with psychomotor symptomatology.  In 
about half of the patients the seizure is preceded by an aura.  Then a 
phase of motionless total unresponsiveness begins lasting for about 10-
15 seconds.  Facial grimace and head turning often precede this phase.  
The head turning has no localizing value. 
 The second phase is longer lasting 20-30 second and consists of 
stereotyped automatic motor activity or “automatisms”.  The most 
common automatisms involve the face and lips.  Chewing movements 
are called de novo automatisms and can arise from either internal or 
external stimuli. Each of these subjective psychic experiences may 
constitute the entire seizure or combinations may occur and proceed to a 
period of unresponsiveness.  The motor components of the seizures 
occur during the later phase and take the form of automatisms.  These 
include lip smacking, Chewing or swallowing movements, fumbling of 
the hands or shuffling of the feet.  Certain complex acts that were 
initiated before the alteration of consciousness such as walking, chewing 
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food, turning the pages of a book or even driving may continue.  
However if asked a specific question or given a command, the patient is 
obviously out of contact.  There may be no response at all or the patient 
may look towards the examiner in a perplexed way or utter a few 
stereotyped words.  The patient is thus confused and in an irritable state, 
may resist or strike out at the examiner. 
 The violence and aggression that are said to characterize patients 
with temporal lobe epilepsy take this form of non-directed oppositional 
resistance in response to restraint during the period of automatic 
behavior (called so, because the patient presumably acts like 
automation).  Unprovoked assaults or outbursts of intense rage or blind 
fury are unusual.  Rarely laughter or roaming may be the most striking 
feature of an automatism (Gelastic epilepsy and Epilepsia procursiva 
respectively); or simply wander aimlessly either as an ictal or postical 
phenomenon (Poriomania).  Dystonic posturing of the arm and leg 
contra lateral to the seizure focus is found to be a frequent 
accompaniment.  After the attack, the patient usually has no memory 
about what was said or done.  Any type of CPS may proceed to tonic 
spasm or other forms of secondary generalized seizures. 
 Seizures of temporal lobe origin can be at times confused with a 
number of psychiatric conditions like hypomania or schizophrenia.  
Some patients will lapse into paranoid, delusional or amnesic psychosis 
for a few days or weeks.  EEG during this period may show no seizure 
activity in the Amygdala and other deep temporal lobe structures.  
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Psychiatrists make the diagnosis of temporal lobe epilepsy rather fairly.  
Helpful in diagnosis is the known occurrence of seizures, amnesia for 
some of the events of the psychosis and seizure discharges in EEG.  
MRI will disclose a temporal lobe lesion CPS in about a third of cases.  
Postictal posturing and paresis of an arm or aphasia helpful in detecting 
the side of lesion. 
 The third or last phase in CPS is the phase of partial 
responsiveness with reactive automatism.  This phase can last for up to 5 
minutes, the patient being confused usually for two to three minutes 
with an individual patient tending to have seizures of the same duration 
on each occasion. 
 Other types of CPS with psychomotor symptomatology include 
the seizures of “temporal lobe syncope” and “frontal lobe epilepsy”.  
Both these seizures have been recognized as specific sub types only 
after the introduction of video recording and EEF telemetry.  The 
seizure of temporal lobe syncope being with loss of tone, which may 
involve the muscles of the head nodding or may fall to the floor.  He or 
she is then unresponsive and confused.  Responsiveness is regained 
slowly, the patient exhibiting reactive automatism of about two minutes 
before full recovery.  The seizures are generally refractory to medical 
therapy and are dangerous because sudden falls lead to frequent injury. 
 The seizures of frontal lobe epilepsy are noted for being ‘motor’ 
and less ‘psychic’ than those arising from the temporal lobe area.  A fall 
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may herald the onset of a seizure followed by vigorous stererotyped 
automatisms consisting of bilateral leg extension, kicking and thrusting 
about and aggressive sexual automatisms. The attacks appear bizarre 
and very often misdiagnosed as ‘hysterical’. Occipital lobe CPS is 
suspected by the initial ictal event.  Simple visual hallucination, eye 
deviation or ictal blindness suggest occipital lobe origin. 
 Inhibitory factors particularly of the cortex and the thalamus 
usually terminate focally originating motor seizures after one to two 
minutes.  In other circumstances, excitation overwhelms inhibition, 
allowing extensive propagation and secondary generalization.  When 
neither side wins this ‘excitatory-inhibitory struggle’, a prolonged or re-
iterative partial motor seizure results.  Several varieties have been 
described. 
The first variety described by Kojevnikov and termed Epilepsia 
partialis continua, consists of repeated Jacksonian seizures characterized 
by a motor march.  Between such attacks, persistent stereotyped, focal 
myoclonic episodes occur, involving the area from which the ‘march’ 
originates.  This may be the most common type occupying a midpoint 
between the following extremes. 
The second variety consists of persistent, stereotyped, focal or 
regional, periodic or quasi-periodic myoclonus without ‘march’.  At the 
other extreme are repetitive attacks or Jacksonian march. 
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Historically, debate has centered on whether such phenomena 
represent Rolandic cortical discharge or sub-cortical disturbance.  The 
close and sustained relationship between the cortex and thalamic nuclei 
in epileptiform events suggests the involvement of both strctures. 
 
 
Studies by Chastrian et al and Thomas et al indicate that epilepsia 
partialis continua and its variants usually represent a regional lesion 
involving the cortex, sometimes in the setting of an anoxic, metabolic or 
septic encephalopathy.  The focal lesion may result from stroke, trauma, 
metastasis or primary tumor; it is usually of recent onset. An old lesion 
is less commonly associated with epilepsia partialis continua unless the 
patient develops a diffuse encephalopathy. 
Complex partial status: 
 In this variety, continuous altered behavior has been observed.  
Complex partial status epilepticus may constist of alternating phases of 
total unresponsiveness and speech arrest with stereotyped automatisms 
and partial responsiveness, with partial speech arrest and quasi-
purposive automatisms.  At times, a Complex partial status may result in 
wandering, a condition termed “fugue state”.  Seizures may be confused 
with psychiatric disease or metabolic or other encephalopathies with 
delirium, i.e., Delirum tremens.  A sudden alteration of behaviour 
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particularly in patients with a previous history of epilepsy should raise 
this possibility.  The usual site of origin is mesial temporal and the 
limbic structures or the frontal areas.  There may also be autonomic 
disturbances such as pupillary dilatation or even fever. 
 
 
Epilepsia partialis continua 9,16,29 
 Epilepsia partialis continua is a form of simple partial status 
epilepticus, usually arising from a focus in the prefrontal motor cortex.   
It is “a spontaneous regular or irregular clonic muscles twistings of 
cerebral cortical origin, sometimes aggravated by sensory stimuli 
continued to one part of the body and continuing for hours, days or 
week”. 
 Upto (50%) 38 of cases particularly in children, one caused by 
Rasmeussen’s encephalitis, chronic inflammatory process of unknown 
etiology affecting one hemisphere and presenting with a progressive 
hemiplegia, seizure including Epilepsia partialis continua and 
sometimes cognitive decline. 
Common causes of seizures of new onset, 9 
A. Primary neurological disorders. 
i. Benign febrile convulsions of childhood. 
ii. Idiopathic epilepsy 
iii. Head trauma 
iv. Stroke of vascular malformation 
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v. Mass lesions 
vi. Meningitis or encephalitis 
vii. Rett’s syndrome and autism 
viii. Alzheimers disease 
ix. Huntington’s disease. 
B. Systemic disorders 
i. Hypoglycemia 
ii. Hyponatremia 
iii. Hyperosmolar states like hyperosmolar non ketotic coma. 
iv. Hypocalcemia 
v. Uremia 
vi. Hepatic encephalopathy 
vii. Porphyria 
viii. Drug overdose 
ix. Drug withdrawal 
x. Global cerebral ischemia 
xi. Hypertensive encephalopathy 
xii. Eclampsia 
xiii. Hyperthermia 
Other causes related to the type of epilepsy 
Generalized seizures 
1. Primary (Idiopathic): Genetic, family history may be present 
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2. Diffuse cerebral insults. 
a. Encephalitis 
b. Anoxia 
c. Storage disorders 
 
3. Metabolic disorders 35 
a. Hypocalcemia 
b. Hyponatremia 
c. Hypoglycemia 
d. Porphyria 
e. Renal failure 
f. Hepatic failure 
g. Hyperglycemia 
4. Drugs and toxins 36 
a. Abstinence (benzodiabepins, barbiturates) 
b. Alcohol 
c. Antidepressants 
d. Phenothiazines 
e. Amphetamines 
f. Local anaesthetics 
g. Metronidazole 
h. Drug and alcohol withdrawal 
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i. Imipramine 
Partial seizures 
1. Cerebral trauma 
a. Birth injury 
b. Head injury-cerebral contusion and hemorrhage 
2. Structural lesions 
a. Vascular Malformation 
b. Aneurysms 
c. Cerebral tumors 
d. Cysts 
e. Hydrocephalus 
3. Infections 
a. Meningitis 
b. Encephalitis 
c. Abscess 
d. Empyema 
e. Syphilis 
f. Neurocysticercosis 
g. Tuberculosis 
h. HIV 
i. Toxoplasmosis 
4. Inflammation 
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a. Sarcoidosis 
b. Multiple sclerosis 
c. Systemic lupus erythematoses 
 
 
5. Metabolic and systemic disorders: 45,47,49,50 
Metabolic and systemic disorders may be associated with seizures 
that abate with correction of the underlying abnormality.  These patients 
are not considered to have epilepsy. 
a. Hypoglycemia: can produce seizures especially when serum 
glucose levels fall to 20-30mg%.  In about 6% of patients, focal 
motor seizure is the initial symptoms of the disorder. 
b. Hyponatremia: may be associated with seizures at serum sodium 
levels below 120 meq/l or at a higher level following a rapid 
decline. 
c. Hyperosmolar states: including both hyperosmolar non ketotic 
hyperglycemia and hypernatremia may lead to seizures when the 
plasma osmolality rises above 330 mosm/l 
d. Hypocalcemia: with serum calcium levels in the range of 4.3 – 
9.2 mg/dl can produce seizures with or without tetany. 
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e. Uremia:  can cause seizures especially when it develops rapidly.  
Seizures are reported during dialysis (dialysis dysequilibrium) 
related to the levels of Aluminium used in the dialysate. 
f. Heptatic encephalopathy: is sometimes associated with 
generalized or focal seizures. 
 
g. Porphyria : is a disorder of Heme biosynthesis that produces 
both neuropathy and seizures.  Bromides are used for treatment as 
most anticonvulsants can exacerbate the disorder and hence 
seizures.  Seizures are seen in 15% of patients with AIP. 
h. Drug overdosage: can exacerbrate epilepsy or can cause seizures 
in non-epieptics. 
i. Drug withdrawal: especially withdrawal from ethanol, sedatives 
or anticonvulsants may be accompanied by one or more GTCS 
that usually occur within 48 hours. 
j. Global cerebral ischemia: may be associated with spontaneous 
myoclonus, action myoclonus, and partial or generalized seizures. 
k. Hypertensive encephalopathy: can present with GTCS or partial 
seizures. 
l. Eclampsia: is diagnosed when a woman who has the clinical 
traid of pre-eclampsia (Systemic hypertension, proteinuria and 
edma) develops seizures or coma. Eclampsia usually occurs in the 
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third trimester, near term, but can occur upto 2 weeks post partum 
period. 
m. Cerebral Venous Thrombosis (CVT): Eclampsia and CVT are 
two conditions prominently associated with seizures during and 
just after pregnancy.  In India 50% of all strokes in women are 
related to pregnancy and puerperium and 90% of these are due to 
sinovenous infarction.  
Clinical features include raised ICT, altered sensorium, 
seizures, focal neurological deficits and crainial nerve palsies. 
Diagnosis can be established by CT / MRI / Angiography.  The 
most frequent direct sign in CT scan is the ‘empty delta sign’ 
(triangular rim of contrast surrounding a clot within the superior 
sagittal sinuses) which is seen in 30% of cases.  Treatment 
includes control of infection, cerebral edema and other supportive 
measures.  Heparinisation has been found to be useful in 
improving the outcome in recent studies. 
n. Hyperthermia: can result from infection, heat stroke, 
hypothalamic lesions and drugs like phencyclindine, 
anticholinergics, neuroleptics, anaesthetic agents and 
neuromuscular blockers.  Clinical features include seizures, 
confusion or coma, shock and renal failure. 
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o. Hypomagnesemia: Serum Magnesium levels less than 1.3m 01/1 
can cause seizures. 
p. Hypophosphatemia: Tonic clonic seizures occur with serum 
phosphate levels less than 1 mg/dl. 
q. Thyroid disease: Seizures occasionally occur in hyperthyroidism.  
Seizures are more common with hypothyroidism and may occur 
in about 25% of patients with myxoedema coma. 
 
Imaging modalities used in diagnosis 19,20 
 At present the two most widely used imaging modalities in neuro-
radiology are CT scan and MRI.  CT is well suited for imaging of the 
bone, calcifications and hemorrhage.  Hence, CT is still the mainstay in 
imaging in the emergency room.  Head trauma, suspected sub-arachnoid 
hemorrhages and fractures of the facial and temporal bones are 
examples. 
 
 CT is comparatively cheap and in available is most of the referral 
hospitals and all tertiary care centers. 
 
 A standard CT examination of the head consists of a series of 
contiguous tomographic sections usually 5 – 10 mm thick from the 
posterior arch of atlas to the vertex.  Most adult head can be covered in 
15 – 20 sections.  In the interest of speed some units prefer to perform a 
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helical scan of the head, which takes little more than 30 seconds, 
accepting a small reduction in image quality.  In general, the 
modification consists of thinner section (1.5 – 3mm), changes in the 
plane of sections, magnification of areas of interest and the use of 
contrasts media, usually intravenous or intrathecal. 
 
 
 
Contrast media used for CT are: 
A. Intravenous : Water soluble iodinated media 
B. Intrathecal : a. Water soluble iodinated media  
    b. Gaseous : air or Xenon 
C. Inhalational : Xenon 
Contra indications for intravenous contrast media are history of 
previous allergy impaired renal functions, asthma, multiple myeloma 
and sickle cell anemia. 
Indications for I.V contract medium hinge on the assumption that 
abnormalities in the blood brain barrier (other than cerebral edema) will 
be present or that a hypervascular lesion will be found.  Most primary 
and secondary intracranial tumors and AV malformations, particularly 
those over the tentorium, are visible without contrast media, but the 
significantly increased accuracy of diagnosis makes contrast enhanced 
scanning the method of choice.  Infective or inflammatory processes, 
certain aneurysms and a small proportion of extracerebal collections 
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may also benefit diagnostically from I.V contract medium.  However in 
none of these categories is the detection rate usefully increased.  The 
preferred CT technique in stroke is without contract medium although 
the latter may be given if perusal of the initial images suggests an 
alternative diagnosis.  Ideally all patients should be scanned in the first 
instance without I.V. contrast medium so that the decision as to whether 
contract medium should be used is based on the clinical and imaging 
findings in each case. 
MRI21, 22, 23 is more sensitive than CT scan as an imaging modality 
in investigating seizure disorders and it is more specific too.  MRI 
utilizes the magnetic properties of H+ ions in tissues when subjected to a 
powerful magnetic field.  MRI can be used to study CNS lesions like 
neoplasm, cerebral edema, cerebral edema, demyelinations, 
degenerative disease and congenital anomalies.  MRI is also routinely 
used for evaluation of those patients who are potential candidates for 
epilepsy surgery, e.g.:Mesial temporal sclerosis.  The contrast agent 
used in MRIs Gadolinium – DTPA.  The use of MRI for evaluation of 
epilepsy in our country is not widespread because of its non availability 
and high cost. 
Positron Emission Tomography (PET) and single Photon 
Emission Computerised Tomography (SPECT) are used to study 
cerebral regional blood flow, metabolic activity and glucose utilization.  
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PET and SPECT can be used to determine the site of origin of seizures.  
In a recent study by Theodore et al, presence of glucose 
hypometabolism was found in the left temporal lobe of 70 – 80% of 
patients with temporal epilepsy, who have undergone surgery.  But even 
in affluent countries these investigative modalities are still largely used 
as research tools only. 
 
 
Hyperglycemia 
Pathophysiology of hyperglycemia 1, 27, 31 
 The findings of the Diabetes Control and Complications Trail 
(DCCT) have confirmed that hyperglycemia is the one single cause of 
cellular toxicity and hence, of complications.  In vitro and in vivo works 
has demonstrated that excess glucose, together with genetic and 
environmental factors causes biochemical alterations that affects 
specific metabolic pathways leading to organ damage and loss of 
function.  These changes include: 
• Polyol pathway disruption 
• Glycation / oxidation disruption 
• Protein kinase C synthesis activation 
• Altered gene expression and 
• Lipoprotein alterations. 
 42
The hypothetical link between hyperglycemia and diabetic 
complications Ref. Flow chart 1. 
The role of Glucose Transport changes in the pathogenesis 
hyperglycemia: 
Glucose transport participates in secretory B cells response 
(GLUT – 2) Hepatic Glucose Production (HGP); peripheral stimulation 
of glucose transport in target tissue (GLUT – 4) skeletal muscle 
accounts for 80% of the glucose disposal.   
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Flow chart No. 1 
HYPOTHETICAL LINKS BETWEEN HYPERGLYCEMIA AN DIABETIC COMPLICATIONS  
 
Diabetes 
Hyperglycemia 
Glucose oxidation pathway ↑ 
OXIDATIVE STRESS 
O2 NO ↓ 
Endothelial dysfunction ↓  
No-dependent vasodilatation 
Micro Vascular Complications 
             Retinopathy   Vasculopathy     Neuropathy           Nephropathy 
MACRO VASCULAR COMPLICATIONS 
CORONARY HEART DISEASE        CEREBRO VASCULAR ACCIDENTS                  PERIPHERAL VASCULAR DISEASE 
Polyol pathway ↑ 
Antioxidant defense 
NADPH ↓ 
Coagulation activation 
hematologic alterations ↑ 
Protein glycosylation 
pathway ↑ 
AGEs ↑ 
No quenching ↑ 
LDL oxidation ↑ 
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GLUT 4 is the major glucose transporter expressed in striated muscle.  
GLUT 4 translocation might be the mechanism responsible for insulin, 
mediated glucose disposal.  Hence, chronic exposure to hyperglycemia and 
hyperinsulinemia reduces the maximal insulin-induced glucose transport 
rate by inhibiting transporter translocation.  
Hyperglycemic state 1, 4 
 Hyperglycemic state is said to occur when there is sustained rise of 
Blood Glucose (BG) beyond definite limits 
1. DIABETES : FPG > 126mg/dl, PPPG > 200mg/dl 
2. IGT:FPG = 110 – 125mg/dl, PPPG = 140 – 200mg/dl 
3. IFG:FPG > 100mg/dl 
Factors leading to hyperglycemia (HPIM 16 ED) 
1. Decreased hepatic glucose uptake 
2. Decreased hepatic glycogen synthesis 
3. Hepatic resistance to Insulin. 
4. Porto systemic glucose shunting 
5. Peripheral insulin resistance 
6. Humoral abnormalities (Serum) 
↑ Glucagon 
↓ Cortisol 
↑ Insulin (↓ in Haemochromatosis) 
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Hyperglycemic status – causes 
- Diabetes (Decreased Insulin secretion and Impaired Insulin 
action) 
- Impaired Fasting Glucose 
- Transient Hyperglycemia 
- Gestational Diabetes – IFG 
- Previous abnormality of Glucose Tolerence 
Mechanism of Hyperglycemic seizures: 57, 58 
1. The Brain glucose utilization is reduced in non ketotic 
hyperglycemia, an increased rate of GABA utilization via the GABA 
shunt may be one of the sources of energy requirements, thereby 
further lowering the GABA level and reducing the threshold of 
seizure activity. 
2. It seems, that an acute cerebral infarct or an older infarct, a scar 
formation, is triggered to produce focal epileptic activity by the 
superimposed metabolic disturbances especially hyperglycemic and 
hyponatremia. 
3. Ketotic hyperglycemia is less frequently associated with seizure 
possibly because of the antiepileptic effect of ketosis. 
4. Practically all, patients who present with epilepsia partials continua 
should have immediate determination of blood glucose levels.  
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Hyperglycemic seizures – Diagnosis 
 In the absence of Ketosis in Diabetes patients with Hyperglycemia 
produce 
1. Abnormal movements like Asterixis 
2. Paroxysmal Choreoathetosis 
3. Partial epileptic seizures: motor / jacksonian. 
It may be the initial or first manifestations of Diabetes Mellitus. 
It may occur in 19% of patients with metabolic abnormalities of Non 
Ketotic Hyperglycemia. 
The prompt management with Insulin and correction of Dehydration 
and osmololity help for early recovery in these patients (HPIM 16 ED). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
MATERIALS AND METHODS 
 This is study included 50 patients diagnosed as Hyperglycemic 
Seizure on the basis of clinical evaluation Biochemical investigations 
and CT scan Brain and Electro Encephalographic studies, who were 
admitted to the Medical wards including neurology and Intensive 
Medical care units of Thanjavur Medical College Hospital, Thanjavur 
during November 2004 to July 2006. 
PATIENT SELECTION:   
The following patients were included: 
1. Patients taken for this study includes Patients admitted with first 
time convulsions who was later found to be Diabetic and whose 
first admission Blood Sugar was in Hyperglycemic level. 
2. Known Diabetic patients who had focal neurological symptoms / 
convulsions whose Blood sugar during convulsions showed 
Hyperglycemic Seizure level. 
3. Other Systemic problem patients who had convulsions during 
their hospital stay and showed Hyperglycemic level of Blood 
glucose and later who were diagnosed as Diabetic patients. 
 
 
 
 
  
The following patients were excluded: 
 All patients with Seizure disorder of varying etiology without 
Hyperglycemia. 
 Patients with Diabetes and Cerebo vascular accidents without 
convulsions. 
 Patients with previously known Structural Brain disorder with 
seizures or patients with convulsions following IV Glucose. 
 Hyperglycemic Seizures was diagnosed on the basis of Diabetic 
patients who had Hyperglycemia with:9,57 
1. Abnormal involuntary Movements. 
2. Paroxysmal choreo athetosis. 
3. Focal Seizures  
4. Generalized Tonic Clonic Seizure (GTCS). 
5. Epilepsia partialis continua. 
 The detailed History and clinical examinations were done as 
outlined in the proforma and they were subjected to routine 
haematological, Biochemical investigations, CT scan evaluation 
including other systemic problem oriented evaluation.  EEG studies was 
done in all patients. 
 
 
 
  
SERUM OSMOLALITY 
 The serum Osmolality was calculated from the following formula: 
SERUM OSMOLALITY  
                           Blood Glucose in mgs         Blood Urea Nitrogen 4 
= 2 x [Na+ + K+] +     +  
        18     2.8 
        Blood Glucose in mgs  Blood Urea in mgs 26 
= 2 x [Na+ + K+] +     +  
        18       6 
 
Serum Osmolality Normal Range = 275 to 295 mosm / kg 24 
1 mosm of Gulcose equals = 180mg/l or 18mg/dl 4 
Urea Nitrogen equals = 28mg/l or 2.8 mg/dl 24 
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RESULTS AND OBSERVATION 
 The total number of patients in this study was 50.  The study was 
done during the period of November 2004 – July 2006 in Thanjavur 
Medical College Hospital. 
AGE DISTRIBUTION 
Table – I 
 
Sl. No. Details 
No. of Patients with 
Hyperglycemia 
seizure diagnosed 
Percentage for 
Total Patients 
1 Age < 19 Years 1 2% 
2 Age 20 – 29 Years 0 0% 
3 Age 30 – 39 Years 2 4% 
4 Age 40 – 49 Years 10 20% 
5 Age 50 – 59 Years 13 26% 
6 Age > 60 Years 24 48% 
Total 50 100% 
 
 The total number of patients included in the study was 50. Out of 
which 1 patient belong to the age group of less than 20 years.  The 
youngest of them was 18 years old.  2 patients belong to age group of  
30 – 39 years.  10 patients belong to age group of 40 – 49 years.  13 
patients belong to age group of 50 – 59 years.  24 patients belong to age 
group of above 60 years. 
 13 patients were below the age of 50 years.  37 patients were 
above the age of 50 years. 
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SEX DISTRIBUTION 
Table – II 
Sl. No. Details Male Female Total  
1 Age < 19 Years 1 0 1 
2 Age 20 – 29 Years 0 0 0 
3 Age 30 – 39 Years 2 0 2 
4 Age 40 – 49 Years 7 3 10 
5 Age 50 – 59 Years 8 5 13 
6 Age > 60 Years 14 10 24 
Total 32 18  
 
 
 Out of 50 patients, 32 were male patients and 18 were female 
patients. 
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ADMISSION STATUS 
Table - III 
 
Sl. No. Details No. of Patient Out 
of 50 patients 
Percentage for 
total patients 
1 First time admission 
with seizures 28 56% 
2 Diabetes Mellitus 
with seizures 22 44% 
 
 Out of 50 study patients, 28 patients had first time seizure without 
known Diabetes.  22 patients had diabetes with seizures. 
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ANALYSIS OF SYMPTOMS SIGN OF HYPERGLYCEMIA 
Table - IV 
 
Sl. No. Details of symptoms No. of patients Percentage for Total Patients 
1 Focal seizures 27 54% 
2 Focal Seizures with Altered Sensorium  6 12% 
3 Focal Seizure with 
speech defect 2 4% 
4 GTCS 6 12% 
5 GTCS with Altered Sensorium 3 6% 
6 GTCS with Speech defect – APHASIA 2 4% 
7 Epilepsia partialis 
continua 4 8% 
Total 50 100% 
  
 Out of 50 patients, 35 patients had focal seizure and 11 patients 
had generalized tonic clonic seizure, 4 patients had epilepsia partialis 
continua features. 
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BLOOD GLUCOSE ANALYSIS 
Table – V 
Sl. No. Blood glucose level in Mgm/dl No. of patients 
Percentage for 
Total no. of 
Patients 
1 < 200 1 2% 
2 200 – 249 11 22% 
3 250 – 299 22 44% 
4 300 – 349 15 30% 
5 350 – 399 1 2% 
6 > 400 0 0% 
Total 50  - 
 
 Among the 50 cases, 1 patient had blood sugar < 200 mg/dl and  
patients had blood sugar level was 200 – 249 mg/dl.  22 patients had   
250 – 299 mg/dl. 15 patients had 300 – 349 mg/dl. One patient had     
350 – 399mg/dl. None of the patient had found blood glucose level  
above 400 mg/dl. 
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OSMOLALITY ANALYSIS 
Table – VI 
Sl. No. Serum Osmolality in 
m.osm/L No. of Patients 
Percentage for 
Total no. of 
Patients 
1 Normal (275 – 295) 5 10% 
2 Abnormal – above 295 45 90% 
Total 50 - 
 
 Among 50 patients serum osmolality was normal in 5 patients.  45 
patients had hyperosmalality. 
 
ACETONE ANALYSIS 
Table – VII 
 
 
Plasma 
acetone Percentage 
Urine 
acetone Percentage 
Positive 1 2% 1 2% 
Negative 49 98% 49 98% 
 
Among 50 patients, Plasma acetone and Urine acetone was 
positive in 1 patient. 
  
CT SCAN BRAIN ANALYSIS 
Table – VIII 
Sl. No. Details No. of Patients 
Percentage for Total 
No. of Patients 
1 Normal 36 72% 
2 Abnormal   
a) Infarct 13 26% 
 
b) Cortical Atrophy 1 2% 
Total 50 - 
 
 Out of 50 study patients, 36 patients had normal CT Scan and 14 
had abnormal CT scan.  In among 14 patients, 13 patients had infarct in 
the CT scan and 1 patient had cortical Atrophy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
CT SCAN SHOWING NORMAL STUDY 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
CT SCAN SHOWING LEFT CAPSULO GANGLIONIC INFARCT

  
EEG SHOWING INTERMITTENT SPIKE AND SHARP WAVE DISCHARGE ON LEFT  
FRONTO PARIETAL REGION 
  
EEG ANALYSIS 
Table - IX 
Sl. No. Details No. of Patients 
Percentage for Total 
No. of Patients 
1 Normal 42 84% 
2 Abnormal   
a) Bilateral epileptiform 
moves on right side 4 8% 
b) Bilateral epileptiform 
moves on left side 2 4% 
 
c) 
Intermittent spike and 
sharp waves 
discharge on left 
parietal leads 
2 4% 
Total 50 100% 
 
Out of 50 study patients, 42 patients had normal EEG and 8 
patients had abnormal EEG.  In among 8 patients, 2 patients had 
intermittent spike and sharp waves discharge on left parietal leads, and 4 
patients had bilateral epileptiform moves on right side and 2 patients 
had epileptiform moves on left side. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
DISCUSSION 
 50 patients who presented with new onset seizure and 
hyperglycemia were analysed as follows: 
 Maccario et al has shown that seizures occurred as the first 
manifestation of Non Ketotic Hyperglycemia. 
 The occurrence of seizure as a presenting features of 
Hyperglycemia with Non Ketotic Hyperglycemia was first emphasized 
by Maccario et al.  in 1965. 39 
Age and Sex: 
In a study conducted by Maccario et al seizures occurred as the 
first manifestation of diabetes in patients above 60 years. 
 In our study 46% of patients had new onset seizures were above 
60 years.  They were found to have Non Ketotic Hyperglycemia 
 Lammouchi T, Grira M, et al,55 studied 22 cases.  11 out of 22 
cases diabetes mellitus had not been diagnosed previously.  In our study 
28 out of 50 cases were not diagnosed previously. 
Seizure types in Hyperglycemia: 
 In a study conducted by Vargese K.S, et al,41 Focal seizure with 
(or) without generalization occurred in 65% of patients. 
 In our study Focal seizure without generalization occurred in 58% 
(29/50) case.  Focal seizure with generalization occurred in 12% (6/50) 
cases. 
  
 Primary generalized seizure occurred in 22% of patients (11/50 
cases). 
 Rector WG,54 Reviewed 158 cases, in his study 44% cases were 
focal seizure.  18% of cases were generalized seizures. 
 Scherer C,40 studied patient more than 50 years, in his study 
partial motor seizure occurred 65% of patients.  In our study 70% of 
patients had focal motor seizure. 
 Venna N, Sabin T.D.,56 study showed that focal seizure is the 
commonest, type in Diabetes Mellitus.  Hyperglycemia is the strongest 
risk factor for focal seizure and stroke. 
Epilepsia Partialis Continua: 
Epilepsia Partialis Continua is one of the early presentation of 
Non Ketotic Hyperglycemia. 
In our study Epilepsia Partialis Continua occurred in 8% of 
patients. 
Singh BM et al,42 studied 21 patients with seizures.  He showed 
Epilepsia Partialis Continua occurred in 9 patients [9/21 43%] with 
Non Ketotic Hyperglycemia. 
Lammouchi T, Grira M, et al,55 studied 22 patient with Non 
Ketotic Hyperglycemia.  Out of which 14% presented with Epilesia 
Partialis Continua in his study. 
  
Singh and Strobos,28 1980, studied 158 cases and his study 
showed 10 patient (6%) had Epilepsia Partialis Continua and in our 
study 8% of patients with Non Ketotic Hyperglycemia had Epilepsia 
Partialis Continua. 
In addition, patients studied in the above literature had 
hyponatremia and hyperosmolality along with Non Ketotic 
Hyperglycemia. 
In our study, 4 patients had hyponatremia and hyperosmolality 
along with Non Ketotic Hyperglycemia. 
Blood sugar: 
 In our study, mean blood sugar was 277.3 mg / dl with the range 
of blood sugar was 191 – 398 mg/dl.  
In two studies conducted by Grant C, Charles Warlow, et al,46 
range of blood sugar was 234 mg / dl to 600 mg / dl among the patients 
with Non Ketotic Hyperglycemia. 
In another study by Scherer C,40 observed that the mean blood 
sugar level was above 340 mg / dl in patients presented with focal 
seizures and Non Ketotic Hyperglycemia.  
Supachai Paiboonpal et al,59 studied 22 patients with Epilepsia 
Partialis Continua and observed range of blood sugar was                    
324 – 742 mg/dl in both Ketotic and Non Ketotic Hyperglycemia. 
  
In another study by, Venna N, Sabin et al, showed hyperglycemia 
is intrinsically epileptogenic and levels of blood glucose triggering 
seizures may be as low as 14 – 20 mmol /L (252 – 360 mg/dl). 
The incidence of blood glucose level with which hyperglycemic 
seizures occurred in our study is comparatively less than their studies 
(191 – 398mg/dl). 
James C. Kolb,52 seizures hyperglycemia evaluate the frequency 
and type of seizure and glucose level of patient.  Level of alterness he 
evaluated in 813 patients with blood glucose level above 400 mg and 
observed only 8 out of 813 patients (1%) had seizures with Non Ketotic 
Hyperglycemia.  He concluded that focal or generalized seizure induced 
by hyperglycemia occurred in the absence of precipitating factors.  This 
study also showed that seizures are rare with blood glucose more than 
400 mg / dl.  In our study patients with blood sugar value more than   
400 mg had no seizures. 
Diabetic Keto Acidosis: 
 Engel and Pedley9 studied, ketotic hyperglycemia is less 
frequently associated with seizure possibly because of the antiepileptic 
effect of ketosis. 
A study by J.J. Mc. Murray51 observed that seizures are not seen 
in Diabetic ketosis because ketones have an antiepileptic effect. 
  
 Vargees KS, et al, studied 40 cases and observed none of the 
patients with Diabetic Ketoacidosis had seizures. 
Scherer C, observed that in the absence of ketoacidosis seizures 
occurred more frequently. 
 In our study 2% of patients with Diabetic Ketoacidosis had 
seizures. 
Hyperosmolality: 
 In our study, 90% of patients had increased osmolality with range 
between (295 – 330m.osm/l), 5 cases (10%) had serum osmolality in the 
normal range (275 – 295m.osm/l). 
 Vargese K.S, et al studied 40 patients with Seizure and 
hyperglycemia observed in 90 % of study group had increased serum 
osmolality. 
 Scherer C,40 observed seizure occurs if serum osmolality is 
normal or slightly elevated. 
Lammouchi T, Grira M, et al55 studied 22 patients with Non 
Ketotic Hyperglycemia and observed that the serum osmolality 
increased in all 22 cases with mild to moderate extent.                           
(266 – 309.2 m.osm/l) 
In our study, 90% of cases had serum osmolality above 
295m.osm/l. 
  
Wasterlain CG Berkovic SF,57,58 reviewed 22 patients with 
Epilepsia Partialis Continua. Patients with Epilepsia Partialis Continua 
had serum osmolality 301.7 m.osm/l. 
In our study, 4 Patients with Epilepsia Partialis Continua had 
serum osmolality above 295 m.osm/l. 
CT Scan Brain: 
 In our study, 36 out of 50 patients (72%) had normal CT Scan 
Brain.  In the remaining 14 cases, 13 patients (26%) had infarct and one 
patient (2%) had cortical atrophy. 
 Vargese K.S, et al studied 40 cases out of which 24 patients 
(60%) had normal CT Scan Brain and 16 patients (40%) with seizures 
had infarct. 
 Lammouchi T, Grira M, et al55 studied 22 cases out of which 17 
patients had normal CT scan Brain.  In our study, 72% of patients had 
normal CT Scan Brain. 
EEG 
 In our study, 8 out of 50 (16%) with hyperglycemic seizures had 
abnormal EEG.9,34 
 In our study, 10 patients with hyperglycemia seizure had 
associated with systemic disease. In among 10 patients, 3 patients had 
hypertension and CAHD but had no evidence of Hypertensive 
Encephalopathy. 
  
 5 patients had renal failure.  Probably the seizure associated with 
these patients may be due to Hyperglycemia or Uremia. 
 2 patients with hypothyroidism had seizure associated with 
hyperglycemia. 
 Almost all patients recovered completely with routine line of 
management with insulin, anti epileptics and dehydration correction.  
However, irrespective of management 2 patients had status epilepticus 
and died and 2 patients had developed coma and died.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
CONCLUSION 
 HYPERGLYCEMIC SEIZURES is a special neuro – endocrine 
syndrome.  Seizures can manifest as the first symptom of Diabetes 
Mellitus. 
Hyperglycemic seizures can occur in Ketotic and Non Ketotic 
Hyperglycemia but commonly in patients with non ketotic 
hyperglycemia. Hyperglycemic seizures is rarely associated with 
Diabetic Keto acidosis. 
 Generalized tonic clonic seizure as the first manifestation of Non 
Ketotic hyperglycemia is found to be rare. 
 Hyperglycemic seizures occurred commonly above the age of     
50 years and the incidence is more in males. 
 Most of the patients with hyperglycemic seizures had blood 
glucose value between 250 – 300 mg/dl. 
 In our study the mean blood glucose value was 277.3 mg/dl 
among patients with hyperglycemic seizures. 
 The minimum blood sugar value at which hyperglycemic seizure 
occurred was 191 mg/dl and maximum blood sugar value at which 
hyperglycemic seizures occurred was 398 mg/dl. 
  
 The osmolality was above the normal range in the maximum of 
90% of cases. 
 The CT Scan brain evaluation showed normal without structural 
brain lesion in 72% of patients. 
EEG was normal in majority of patients with Non Ketotic 
hyperglycemic seizures. 
The correction of Non Ketotic hyperglycemia with insulin and IV 
fluids showed early and complete recovery.  
From the above study, it is shown that all patient with new onset 
seizures above the age of 50 years should also be thought of Diabetes 
Mellitus and evaluated for it.   
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
EVALUATION OF CLINICAL PROFILE OF 
HYPERGLYCEMIC SEIZURES 
 
NAME:     AGE/SEX:       M/F  
 
IP. No.:  WARD:  OCCUPATION: 
 
ADMITTING COMPLAINTS: 
a. CONVULSIONS         c. FOCAL NEURO LOGICAL 
SYMPTOMS 
b. UNCONSCIOUSNESS        d. OTHERS 
 
HISTORY OF FITS: 
a. WHETHER, SINGLE SEIZURE  REPEATED SEIZURE   
b. TYPE OF SEIZURE:   FOCAL / GTCS / EPC / EME / CPS / TLE / PLEDS /  
GCSE / MYOCLONIC / NCSE / GEVS / PARTIAL 
MOTOR SEIZURE / NOCTURNAL 
 
ASSOCIATED CONDITION: LOC / POST ICTAL CONFUSION /  
     RESIDUAL PROBLEM 
 
PAST HISTORY: 
a. DIABETES      c. CAHD       / COPD      / TB 
b. HYPERTENSION     d. OTHERS   
 
TREATMENT HISTORY: 
a. DIABETIC TREATMENT:    OHA      INSULIN         
b. NO TREATMENT        OTHERS 
EXAMINATION: 
a. PALLOR     c. JAUNDICE 
b. FEVER       
VITAL SIGNS: PULSE:  BP (mm / Hg):  
EXAMINATION OF CENTRAL NERVOUS SYSTEM: 
1.  HIGHER FUNCTIONS:   3. SENSORY SYSTEM: N /    + / - 
     a. Conscious / Confusion   + / - 4. MOTOR SYSTEM:   
  
     b. Stupor / Coma   + / -     a. Mono Paresis R/L:UL/LL + / - 
     c. Speech: N /   + / -     b. Hemi Paresis R/L:UL/LL + / -2. 
CRANIAL NERVES: CN:  PALSY R/L  + / -    c. Quadri Paresis     + / - 
           5. OTHERS      + / - 
OTHER SYSTEMS:  CVS:   RS:   ABDOMEN: 
DIABETIC COMPLICATIONS: 
    1. NEPHROPATHY:  MICRO / MACRO / AZOT 4. RETINOPATHY 
    2. NEUROPATHY:    PN / MN     5. OTHERS 
       AMYO / DIAB - FOOT 
    3. ANS: GASTOPATHY / ORTHO HT / IMPOTENCE /  
      BLADDER DISTURBANCE 
 
INVESTIGATION: 
Blood HB      gm%        Tc:     Dc: P.        L.              E.            M.           
BIO-CHEMISTRY               Date :   
Blood Sugar (Random) (mg/dl)    :   
              (Fasting) (mg/dl) :   
                    (PP) (mg/dl)  :   
Plasma Acetone    
Blood Urea (mg / dl)   
Serum Creatinine (mg / dl)   
Serum Sodium (Meq / L)   
Serum Potassium (Meq / L)   
Serum Osmolality (m.osm/L)   
Urine Albumin   
Urine Acetone   
Others   
 
ECG  
CHEST X RAYS  
CT SCAN BRAIN  
EEG  
 
OUTCOME: 
1. RECOVERY WITH : 
a. OHA  
b. INSULIN      
c. AED:    DPH   /     CBZ     /      SVP     /    GAR 
2. TOTAL RECOVERY 
  
3. PARTIAL RECOVERY 
4. DIED 
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